Targeted Gene Therapy Rejuvenate Bio is developing gene therapy for canine osteoarthritis, presenting an opportunity to collaborate with veterinary clinics or animal health companies for product adoption and expansion.
Expert Medical Leadership Having key personnel like Chief Medical Officer Deborah Ascheim can be leveraged to engage in partnerships with medical institutions or conferences to showcase expertise and attract potential collaborators.
Cutting-Edge Tech Stack Utilization of a diverse tech stack including Microsoft and Google technologies showcases innovation, offering an angle to engage with technology companies for synergistic product development or integrations.
Contribution to Market Research Being in the biotechnology research industry, Rejuvenate Bio's insights from preclinical efficacy data can be presented at industry events or conferences to position the company as an industry leader and attract research collaborations.
Investment and Expansion Receiving funding and investments like that from LifeSpan Vision Ventures offers an opportunity to explore collaborations with other funded startups, venture capital firms, or initiate expansion strategies to drive growth and enhance market presence.
Rejuvenate Bio uses 8 technology products and services including Squarespace, Cart Functionality, Typekit, and more. Explore Rejuvenate Bio's tech stack below.
| Rejuvenate Bio Email Formats | Percentage |
| First@rejuvenatebio.com | 50% |
| First@rejuvenatebio.com | 50% |
Biotechnology ResearchUnited States11-50 Employees
Rejuvenate Bio is targeting the core drivers of chronic age-related diseases by unlocking the power of gene expression and epigenetic reprogramming to reverse pre-existing heart disease, metabolic disease, and kidney failure in humans.
Company Overview
Media & News
Funding & FinancialsRejuvenate Bio has raised a total of $4M of funding over 3 rounds. Their latest funding round was raised on Jul 01, 2024 in the amount of $4M.
Rejuvenate Bio's revenue is in the range of $10M
Funding & FinancialsRejuvenate Bio has raised a total of $4M of funding over 3 rounds. Their latest funding round was raised on Jul 01, 2024 in the amount of $4M.
Rejuvenate Bio's revenue is in the range of $10M
1-888-653-2347 
support@leadiq.com